Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Hgb Dermalife AB
AB
Active
Org 5569711632
Blåhakegatan 4, 254 49
Helsingborg
Medical specialists activities
·
NACE 8622
Est. 2014 · 12 years old
3 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Hgb Dermalife AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
12M
9M
6M
3M
0M
2020: 10M
10M
2020
2021: 9M (-10% vs 2020)
9M
-10%
2021
2022: 9M (0% vs 2021)
9M
0%
2022
2023: 4M (-56% vs 2022)
4M
-56%
2023
2024: 10M (+150% vs 2023)
10M
+150%
2024
EBITDA
SEK millions
9M
7M
4M
2M
0M
2020: 7M
7M
2020
2021: 7M (0% vs 2020)
7M
0%
2021
2022: 7M (0% vs 2021)
7M
0%
2022
2023: 2M (-71% vs 2022)
2M
-71%
2023
2024: 7M (+250% vs 2023)
7M
+250%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
9 670
4 430
9 202
9 163
9 536
Staff expenses
—
—
—
—
—
EBITDA
7 220
2 428
7 017
6 953
7 288
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
7 220
2 428
7 017
6 953
7 288
Net financials
575
508
31
−17
−15
Profit before tax
7 045
2 503
5 695
5 431
5 443
Tax
−1 537
−562
−1 192
−1 134
−1 185
Net profit
5 508
1 941
4 503
4 297
4 258
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
42 621
38 102
36 134
30 824
25 938
Equity
29 777
24 818
23 427
19 474
15 677
Long-term debt
0
0
0
0
0
Short-term debt
1 778
2 967
2 824
2 820
3 236
Total debt
1 778
2 967
2 824
2 820
3 236
Financial ratios
5-year trend
EBITDA margin
74,7 %
This company
15,8 %
Market median
This company
Market median
373% above market
2020
2024
Equity ratio
69,9 %
This company
38,2 %
Market median
This company
Market median
83% above market
2020
2024
Return on equity
18,5 %
This company
18,4 %
Market median
This company
Market median
1% above market
2020
2024
Net profit margin
57,0 %
This company
8,1 %
Market median
This company
Market median
604% above market
2020
2024
Asset turnover
0,23×
This company
1,12×
Market median
This company
Market median
79% below market
2020
2024
Debt / equity
0,43×
This company
0,62×
Market median
This company
Market median
31% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Hgb Dermalife AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
